STZ - Constellation Brands, Inc.

NYSE - NYSE Delayed Price. Currency in USD
218.57
+3.40 (+1.58%)
At close: 4:03PM EDT

218.60 +0.03 (0.01%)
After hours: 6:49PM EDT

Stock chart is not supported by your current browser
Previous Close215.17
Open215.20
Bid0.00 x 1000
Ask0.00 x 1100
Day's Range214.50 - 219.43
52 Week Range197.32 - 236.62
Volume1,882,852
Avg. Volume2,184,107
Market Cap41.844B
Beta-0.05
PE Ratio (TTM)16.39
EPS (TTM)13.33
Earnings DateOct 4, 2018
Forward Dividend & Yield2.96 (1.40%)
Ex-Dividend Date2018-08-09
1y Target Est243.29
Trade prices are not sourced from all markets
  • TheStreet.com5 hours ago

    Canopy Growth CEO: Traditional Firms Will See They Must Get Into Legal Cannabis

    Real Money's Kevin Curran talked this week with CEO Bruce Linton of Canopy Growth Corp. , one of the hot legal-cannabis stocks that are taking financial markets by storm. Click here to read Part ...

  • 3 Legal Highs for Your Portfolio
    InvestorPlace6 hours ago

    3 Legal Highs for Your Portfolio

    Marijuana stocks are hot in today’s market, but pot stocks are not the only way for you to profit from the habits of other people. You can go with diversity in Constellation Brands (NYSE:STZ), you can go for global growth with Anheuser Busch InBev (NYSE:BUD), or you can go for U.S. growth with The Boston Beer Co. (NYSE:SAM). Constellation is based in upstate New York as a wine company but is better known today for its beer and spirits.

  • TheStreet.com8 hours ago

    Despite Taking Some Weed, Constellation Brands Charts Are Still Bearish

    was reviewed in late June before it announced an investment in Canopy Growth Corp. , where I wrote that, "The risk for STZ is that if prices break below $215 we could see further declines to $205 (the February low) and then perhaps $195 or so based on the Point and Figure target. In this updated daily bar chart of STZ, below, we can see that prices have rallied to the underside of the cresting 200-day moving average line.

  • Will Aurora Cannabis Be The Next Marijuana Stock To Tap U.S. Investors
    Motley Fool10 hours ago

    Will Aurora Cannabis Be The Next Marijuana Stock To Tap U.S. Investors

    Management is considering listing its shares on a major stock exchange in America.

  • 3 Beverage Giants That Should Be Looking for a Cannabis Partner
    Motley Fool12 hours ago

    3 Beverage Giants That Should Be Looking for a Cannabis Partner

    Sluggish sales could coerce these well-known beverage makers to turn to the green rush.

  • Investopedia16 hours ago

    6 Marijuana Stock Picks: Cowen

    Midterm elections will  “deliver incremental catalysts" to the marijuana industry regardless of which political party emerges victorious, according to analysts. In a research note, reported on by CNBC, Cowen's Washington Research Group said that a Democratic win would be better for the sector, before concluding that the Republican party holding onto its majority could also boost pot stocks more than before. "Few industries are better positioned than cannabis regardless of outcome," Cowen senior analyst Vivien Azer wrote in the note.

  • TheStreet.comyesterday

    Tilray Shares Are Going Absolutely Haywire -- Here's Why

    It may end badly, but for nimble traders in Tilray the good times are likely to continue flowing as the hype on the company's prospects reach fever pitch levels. Clearly, investors have bought into Tilray's pitch hook, line and sinker. "This industry [cannabis] is disrupting the pharmaceutical industry, cannabis is a threat to prescription based painkillers primarily opiods," explained Kennedy in an interview with TheStreet on the day of its July IPO.

  • InvestorPlaceyesterday

    Why Tilray Stock Is Bound to Fall Hard Sooner or Later

    In late July, cannabis company Tilray (NASDAQ:TLRY) went public at $17 per share. Today, exactly two months after its IPO, Tilray stock crossed above $200 and is showing no signs of slowing. As of this writing, stock in Tilray is closing in on $240.

  • TheStreet.comyesterday

    How to Play Tilray With Options

    The question on everyone's mind now is: "Where is Tilray's top?" I have no idea, but my fellow columnist Jim "Rev Shark" DePorre recently had a terrific write-up comparing TLRY's rise to the way Ponzi Schemes play out. By contrast, Tilray still offers investors what I call "The Dream" -- a chance to participate in the perfect deal with the perfect company.

  • Barrons.comyesterday

    Marijuana Stocks Just Keep Soaring Higher. But Even the Bulls See a Bubble

    Marijuana stocks are riding a wave of giddy news, with a rally by Tilray reaching a point of absolute hysteria. But don’t get too high on all these surging pot stocks.

  • TheStreet.comyesterday

    Tilray Shares Are Hot Following CEO's Interview With Jim Cramer

    CEO Brendan Kennedy had to say to Jim Cramer Tuesday night on "Mad Money" or the company's stock is a bubble waiting to burst. Kennedy touted his Canadian cannabis business as a smart hedge for the world's largest pharmaceutical companies in an interview with Cramer on CNBC. "Cannabis is a substitute for prescription painkillers, prescription opioids, and so if you're an investor in a pharmaceutical company or you're a pharmaceutical company, you have to hedge the offset from cannabis substitution," Kennedy told Cramer.

  • CNBCyesterday

    Booming rally in marijuana stocks such as Tilray could get another boost from midterm elections

    “Few industries are better positioned than cannabis regardless of outcome,” says Cowen analyst Vivien Azer. A total blue wave would be the best outcome. The removal of Attorney General Jeff Sessions, who has been vehemently against legalizing marijuana, is also seeming more likely after comments by President Trump this week.

  • InvestorPlace2 days ago

    Why Tilray Stock Isn’t Worth $100

    Cannabis mania is in full swing, and the stock that is creating the most hype is Tilray (NASDAQ:TLRY). Seven weeks ago, Canadian cannabis supplier Tilray went public at $17 per share. The alcoholic beverage market has produced multiple $50 billion-plus companies, including one $170 billion company.

  • TheStreet.com2 days ago

    Experts Are High on Cannabis Stocks' 2019 Prospects

    The red-hot legal-cannabis market could have an even bigger year in 2019 than it did in 2018 as traditional companies see too much green in legalized pot to ignore. The Pew Research Center found that the percentage of Americans who favor legalizing pot has grown to 61% today from just 12% in 1969 when Pew first polled on the issue.

  • Now is the Time to Invest in Marijuana Stocks
    InvestorPlace2 days ago

    Now is the Time to Invest in Marijuana Stocks

    In the fall of 1996, California voters passed Proposition 215, a landmark piece of legislation that made medical marijuana legal across the state. It was the first law in the country making marijuana legal on the state level, and it reversed decades of precedent in the United States. Fast forward to early 2018 and 30 states had legalized medical marijuana and nine had legalized recreational marijuana.

  • 5 Stocks to Buy Amid a Prolonged Trade War Slump
    InvestorPlace2 days ago

    5 Stocks to Buy Amid a Prolonged Trade War Slump

    Yesterday, President Donald Trump announced a new round of tariffs on Chinese goods — $200 billion to be exact. In response, China issued a $60 billion levy on U.S. goods. In an increasingly global economy, prospects for a trade war with China tend to foster nervousness among investors.

  • Benzinga2 days ago

    The Companies That Could Benefit From An Aurora Cannabis-Coca-Cola Deal

    Just look at the deal Canopy Growth Corp (NYSE: CGC) landed with Constellation Brands (NYSE: STZ) just two months ago. That deal, which had Constellation Brands pony up $4 billion for a piece of Canopy, launched a huge run on cannabis stocks. While Canopy Growth Corporation shot up nearly 30 percent on the news, we saw roughly a half dozen other cannabis stocks tack on double-digits gains too. The Coca-Cola Co (NYSE: KO) said it was closely watching the cannabis-infused drinks market, Reuters reported Monday.

  • InvestorPlace2 days ago

    A New Risk Emerges for Tilray Stock

    Anyone who holds stock in a Canadian marijuana company, including Tilray (NASDAQ:TLRY), had their nerves rattled on September 14. “If you work for the industry, that is grounds for inadmissibility,” Todd Owen, executive assistant commissioner of the U.S. Customs and Border Protection Agency’s Office of Field Operations, told Politico.

  • Investopedia2 days ago

    Where Are Coca-Cola Shares Headed After Big News?

    Coca-Cola's deal with Costa and a brewing deal in the cannabis industry could introduce some volatility, which has traders watching these levels.

  • InvestorPlace2 days ago

    3 Reasons Why Coca-Cola Stock Won’t Benefit from a CBD Beverage

    As an integral component of Americana, Coca-Cola (NYSE:KO) doesn’t really generate much news. While Coca-Cola stock earns respect for turning around its business and making its products relevant to today’s youth, the soft-drink sector is extremely competitive. Plus, it could spark a new reason to invest in Coca-Cola stock.

  • 3 Reasons an Aurora Cannabis-Coca-Cola Tie-Up Would Make Perfect Sense
    Motley Fool2 days ago

    3 Reasons an Aurora Cannabis-Coca-Cola Tie-Up Would Make Perfect Sense

    Is another mega-deal about to unfold in the marijuana space?

  • Motley Fool2 days ago

    WageWorks' Very Bad Day

    Down 15% might seem like a buying opportunity, but long-term investors probably don't want to touch this hot potato.

  • Investopedia3 days ago

    Marijuana Short Sellers Have Lost $626M Since August: Report

    Betting against cannabis stocks is becoming an increasingly expensive occupation. Short sellers have lost $490 million year-to-date betting against the sector and $626 million since the start of August, according to S3 Partners, as pot stocks rallied off the legalization of cannabis in some countries and investment interest from some of the world's biggest beverage companies. Research from the financial analytics firm showed that an increasing number of investors responded to excitement surrounding the sector’s prospects by betting against 33 stocks and exchange-traded funds (ETFs) tracking the industry.

  • Coca-Cola to Quench Market Thirst with Cannabis-Infused Beverages
    Market Realist3 days ago

    Coca-Cola to Quench Market Thirst with Cannabis-Infused Beverages

    Coca-Cola to Quench Market Thirst with Cannabis-Infused BeveragesCoca-Cola to develop cannabis drinks

  • MarketWatch3 days ago

    Coca-Cola says it's 'closely watching' the opportunities in CBD-infused beverages

    Coca-Cola Co. confirmed on Monday that it is considering the opportunities in CBD-infused beverages, drinks that contain the non-psychoactive ingredient in marijuana, cannabidiol. In a statement, Coca-Cola said: "Along with many others in the beverage industry, we are closely watching the growth of non-psychoactive CBD as an ingredient in functional wellness beverages around the world. The space is evolving quickly. No decisions have been made at this time." The largest beverage company in the world would be joining other big names including Molson Coors Co. and Constellation Brands Inc. that have made investments in the space. Coca-Cola and other carbonated-beverage businesses have sought out new products in areas like bottled water and wellness drinks as soda consumption has declined. Interest in the space has driven up shares of cannabis companies like Canopy Growth Corp. nearly 107% for the year so far. According to Bloomberg, Coca-Cola is in discussions with Aurora Cannabis Inc. about new products. Coca-Cola shares have edged up 0.2% for 2018 to date, and the Dow Jones Industrial Average is up 5.8% for the period.